We examined the concentrations of lactate dehydrogenase in the cerebrospinal fluid of 25 patients with strokes and 15 patients with transient ischemic attacks <8 hours after the onset of the vascular event and in a control group of 21 patients. We found significantly higher concentrations in the stroke patients (40.9 ±14.5 units/1) than in the transient ischemic attack patients (11.8±2.9 units/1,p<0.001) and the controls (112±6.7 units/1,/?<0.001). Among the stroke patients, we found a significantly higher lactate dehydrogenase concentration in those with cortical strokes (n = 12, 50 ±123 units/1) than in those with lacunar white matter infarcts (n=5, 26.4 ±6.5 units/1; p< 0.001) and those with basal ganglia infarcts (n=8, 36-37 ±11.7 units/1; p<0.05). Our study offers a supplementary examination for diagnosing cortical or subcortical infarction during the early stage of the event, with the possibility of distinguishing precisely stroke from transient ischemic attack during the first hours after onset of the event {Stroke 1990;21:854-857) E stimation of the recovery potential and neurologic outcome during the initial stages of ischemic cerebrovascular events is of therapeutic and prognostic importance. The limited value of computed tomography (CT) as a diagnostic procedure during the first hours after stroke onset justifies searching for an additional sensitive prognostic marker.
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We examined the concentrations of lactate dehydrogenase in the cerebrospinal fluid of 25 patients with strokes and 15 patients with transient ischemic attacks <8 hours after the onset of the vascular event and in a control group of 21 patients. We found significantly higher concentrations in the stroke patients (40.9 ±14.5 units/1) than in the transient ischemic attack patients (11.8±2.9 units/1,p<0.001) and the controls (112±6.7 units/1,/?<0.001). Among the stroke patients, we found a significantly higher lactate dehydrogenase concentration in those with cortical strokes (n = 12, 50 ±123 units/1) than in those with lacunar white matter infarcts (n=5, 26.4 ±6.5 units/1; p< 0.001) and those with basal ganglia infarcts (n=8, 36-37 ±11.7 units/1; p<0.05). Our study offers a supplementary examination for diagnosing cortical or subcortical infarction during the early stage of the event, with the possibility of distinguishing precisely stroke from transient ischemic attack during the first hours after onset of the event {Stroke 1990;21:854-857) E stimation of the recovery potential and neurologic outcome during the initial stages of ischemic cerebrovascular events is of therapeutic and prognostic importance. The limited value of computed tomography (CT) as a diagnostic procedure during the first hours after stroke onset justifies searching for an additional sensitive prognostic marker.
Previous studies have documented elevated concentrations of various enzymes in the cerebrospinal fluid (CSF) of persons with stroke, and significantly elevated concentrations of lactate dehydrogenase (LDH), 1 9 An increase in the concentration of LDH without elevation of the concentrations of other enzymes in the CSF has been documented even in patients with lacunar infarcts 9 and transient minor dysfunctions. 8 However, these findings were demonstrated during a later stage of the event, at the peak of LDH levels (48-96 hours after infarction). 8 The sensitivity of LDH as a marker in patients with mild and moderate strokes reflects the fact that this enzyme has a higher concentration in brain tissue than glutamic-oxaloacetic transaminase and is more thermostable than creatine kinase. 10 We investigated the concentrations of LDH in the CSF of patients during the initial stages of stroke and transient ischemic attack (TTA), and we correlated the concentrations with proximity of the infarcts to the subarachnoid space and with their volumes.
Subjects and Methods
We examined 25 patients with strokes (17 men and eight women, mean±SD age 65.9±12.1 years) and 15 patients with TIAs (10 men and five women, mean±SD age 59.8±9.0 years). We excluded those with a history of previous stroke, convulsive disorder, or migraine from the study. Diagnosis of stroke or TTA was based on the findings of repeated neurologic examinations, electroencephalography (EEG), and brain CT. The patients were examined neurologically on five occasions by the same examiners; EEG was repeated 1, 2, and 10 days after the onset of symptoms; and brain CT was performed ^24 hours and 8 days after admission. Volume of the infarct was calculated by dividing half of the product of the horizontal dimensions of the infarct by the number of CT cuts. We assayed LDH concentration in the CSF of all patients as a diagnostic procedure :S8 hours after the onset of symptoms. We removed 3 ml CSF from each patient under similar conditions. The CSF was stored at -70° C and examined <72 hours after the lumbar puncture. We determined the concentration of LDH using a centrifugation analyzer (Model N. 500, Medtechnica), with kits from Boehringer Mannheim GmbH (FRG). We also analyzed the cell count, the concentrations of protein and glucose in the CSF, and the concentration of LDH in the serum.
We compared the concentrations of LDH in the CSF of the stroke and TIA patients with that of 21 control patients (10 men and 11 women, mean±SD age 45.8±15.6 years). Statistical analysis consisted of one-way analysis of variance for the three groups, pair-wise comparison between subgroups using the Bonferroni test, and Pearson correlation with the variables infarct volume, time after lumbar puncture, cell count, protein and glucose concentrations, and LDH concentration in the serum. Results are reported as mean±SD.
Results
All 25 patients with an acute stroke had motor deficits; 15 suffered from hemihypesthesia, seven had mixed aphasia, seven had motor aphasia, one had sensory aphasia, and six had hemianopsia. Among the 15 patients who had a TIA, 12 had motor deficits, four had sensory deficits, one had mixed aphasia, six had motor aphasia, and two suffered from transient global amnesia. All neurologic deficits disappeared <24 hours after the onset of the event. We found no evidence of a brain lesion on repeated CT scans and no paroxysmal discharge in any EEG examination in any TIA patient.
We further divided the stroke patients into three subgroups according to the location of the infarct on CT. Twelve patients (nine men and three women) had cortical infarcts, with focal slow disturbances on EEG that confirmed the CT findings; five patients (three men and two women) had lacunar infarcts of the white matter; and eight patients (four men and four women) had infarcts of the basal ganglia with no EEG abnormalities.
We found significantly higher CSF LDH levels in the stroke patients than in the TIA patients (40.9+14.5 vs. 11.8±2.9 units/1, /?<0.001) and the controls (40.9±14.5 vs. 11.2±6.7 units/1, /?<0.001) and no significant differences between the TIA patients and the controls (/J=0.974) (Figure 1) . Among the stroke patients, a significantly higher CSF LDH concentration was found in the subgroup with cortical strokes than in the subgroup with lacunar infarcts (50±12.3 vs. 26.4±6.5 units/1, /?<0.001) and the subgroup with basal ganglia infarcts (50±12.3 vs. 36.37±11.7 units/1, /?<0.05). There were no significant differences in CSF LDH level between the subgroup with lacunar infarcts and the subgroup with basal ganglia infarcts (p=0.2128) (Figure 2 ) and no correlation between the timing of lumbar puncture and the CSF LDH level (/-=0.247,/J=0.117).
There was also no correlation between the infarct volume and the CSF LDH levels in any subgroup (p=0.2) or between the LDH concentrations in the 
FIGURE 1. Bar graph. Concentrations of lactate dehydrogenase (LDH) in cerebrospinal fluid (CSF) of 25 patients with stroke. (CVA), 15 patients with transient ischemic attack (TIA), and 21 controls.
CSF and the serum. There was no correlation between the CSF LDH concentration and the cell count or the protein and glucose levels in the CSF (Table 1) . brain injury. 16 Although various studies have proven that there is a high concentration of it in brain tissue, 17 creatine kinase level in the CSF of patients with mild or moderate strokes is much lower than that of glutamic-oxaloacetic transaminase or LDH. These levels therefore cannot be used as diagnostic tools. 8 - 9 The reason for the lack of an increased concentration of creatine kinase in the CSF of such patients is its rapid denaturation and deactivation after release into the extracellular space.
Discussion
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LDH was found to be the most sensitive CSF enzyme in indicating cerebrovascular events. A significantly increased level has been demonstrated in patients with hemorrhagic infarcts, 18 mild and moderate strokes, 8 small lacunar infarcts, 9 and even TIAs. 8 Nevertheless, LDH appears in the CSF later than creatine kinase and reaches maximal activity 48-120 hours after infarction. 8 -15 Other enzymes assayed in the CSF of patients with strokes appear only later after the event. Lactoferrin, lysozyme, and microglobulin ft were observed in the CSF of persons with hemorrhagic infarcts 2-3 days after the event. 19 Adenylate kinase and glutathion appear in the CSF of patients with strokes combined with severe edema as a result of plasma membrane damage even 5 days after infarction. 20 An increase in the concentration of adenylate kinase was found especially in the CSF of hypoxic newborns. 21 We examined LDH concentrations in patients with strokes or TIAs during the initial stages of the event. This study demonstrates a significantly increased concentration of LDH in the CSF of stroke patients, with no similar elevation in TIA patients. Previous studies that examined the enzyme level during later stages found an increase in LDH concentration in both groups, with a significantly higher level in the stroke patients. 8 Our findings demonstrate the sensitivity of the CSF LDH level as a diagnostic and prognostic marker, especially during the initial stages of cerebrovascular events.
Examination of the LDH concentration among the stroke patients revealed a significant difference between those with cortical compared with subcortical ischemic lesions during the first hours following infarction. Recent series have shown an increased CSF LDH level in patients with cortical infarcts and a mild elevation in those with lacunar infarcts >16 hours after the onset of the stroke. 9 A correlation between the volume of the ischemic lesion and the CSF LDH level was not found in our study but has been documented in other series.
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The difference between these findings can be explained by the very early stage of examination in our study. We believe that during the initial stage, the increase in LDH concentration is related more to proximity of the lesion to the subarachnoid space than to volume of the infarct. 22 Considering our results, we suggest that the examination of LDH concentration in the CSF during the first hours after stroke onset may be of diagnostic and prognostic usefulness. This examination offers a simple procedure with which to recognize patients with poor prognoses. Diagnosis of a patient's recovery potential within the first hours after the event is important for management of such cases. In addition, the appearance of LDH in the CSF may provide supplementary information for the diagnosis of cortical versus subcortical infarction, even before evidence of a brain lesion can be found on CT. We also suggest that LDH in the CSF may be useful for recognizing those patients at high risk of developing severe stroke. Such findings could be important for preventive treatment.
